Economics & Business
AbbVie Inc
AbbVie Inc. is a multinational American pharmaceutical company that has become one of the largest and most successful pharmaceutical companies in the world, known for its innovative treatments in various medical fields.
## Overview
AbbVie Inc. is a pharmaceutical company that was spun off from **Abbott Laboratories** in 2013. The company's name was derived from the first two letters of its parent company, **A**bbott, and **V**ie, which is a reference to the Latin phrase "via," symbolizing the company's focus on finding new paths to healthcare. **AbbVie** is headquartered in **North Chicago, Illinois**, and has a diverse portfolio of pharmaceutical products that cater to various medical needs, including autoimmune diseases, oncology, and virology.
**AbbVie** has evolved significantly since its inception, leveraging its research and development capabilities to create innovative treatments that have changed the lives of millions of people worldwide. The company has a strong presence in the global pharmaceutical market and has been recognized for its commitment to innovation, patient care, and sustainability.
## History/Background
**AbbVie** was established in 2013 after **Abbott Laboratories** separated its research-based pharmaceutical business, which included its global portfolio of branded generic pharmaceuticals, biologics, and vaccines. The spin-off was motivated by the desire to create a more focused and agile company that could capitalize on growth opportunities in the pharmaceutical industry. **AbbVie** began trading on the **New York Stock Exchange** under the ticker symbol **ABBV**.
The company's early years were marked by significant investments in research and development, as well as strategic acquisitions that expanded its pipeline of innovative treatments. **AbbVie** acquired **Phyton Biotech**, a biopharmaceutical company focused on developing innovative treatments for chronic diseases, in 2013. In 2014, the company acquired **Skyepharma**, a biopharmaceutical company with expertise in formulation development.
## Key Information
**AbbVie** has a diverse portfolio of pharmaceutical products that cater to various medical needs. The company's flagship products include:
- **Humira**, a biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.
- **Imbruvica**, a medication used to treat various types of cancer, including mantle cell lymphoma and marginal zone lymphoma.
- **Venclexta**, a medication used to treat various types of blood cancer, including acute myeloid leukemia and chronic lymphocytic leukemia.
- **Skyla**, a medication used to prevent pregnancy in women.
**AbbVie** has been recognized for its commitment to innovation, patient care, and sustainability. The company has been included in the **Dow Jones Sustainability Index**, which recognizes companies that have demonstrated strong sustainability performance.
## Significance
**AbbVie** has become one of the largest and most successful pharmaceutical companies in the world, known for its innovative treatments in various medical fields. The company's commitment to innovation, patient care, and sustainability has made it a leader in the pharmaceutical industry. **AbbVie** continues to invest in research and development, with a focus on creating new treatments that address unmet medical needs.
INFOBOX:
- Name: AbbVie Inc.
- Type: Pharmaceutical company
- Date: 2013 (spun off from Abbott Laboratories)
- Location: North Chicago, Illinois
- Known For: Developing innovative treatments for autoimmune diseases, oncology, and virology
TAGS: Pharmaceutical company, autoimmune diseases, oncology, virology, research and development, patient care, sustainability, innovation, Dow Jones Sustainability Index.
Max Fortune
4
3 min read